Urologiia
Peer-review scientific medical journal
Editor-in-chief
- Editor–in-Chief – Academician of the Russian Academy of Sciences, MD, Professor, Petr. V. Glybochko , Rector of the Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of the Russian Federation (Sechenovskiy University)
About P. V. Glybochko https://www.sechenov.ru/univers/about_lecturer/1197/
Pubmed Profile: https://pubmed.ncbi.nlm.nih.gov/?term=Glybochko+PV&cauthor_id=31131643
Scopus ID: 26435273000
https://orcid.org/0000-0002-5541-2251
Publisher
-
LLC “Bionika Media”
Founders
-
Russian Society Urology
-
First Sechenov Moscow State Medical University
WEB official
Aims and Scope
Urologia (Urology) is a scientific peer-reviewed medical journal that aims to publish quality articles highlighting the latest achievements in the field of urology, andrology, nephrology and urologic oncology. In accordance with this goal, we publish timely, practical, and state-of-the-art contributions on clinical research and experience in the relevant field. The Journal encompasses all aspects of basic urological research, etiology, pathogenesis, advanced methods of diagnosis, prevention and treatment of genitourinary system diseases, inflammation of various etiologies, urolithiasis, renal insufficiency, reconstructive surgery, andrology and pediatric urology.
The audience is primarily urologists, andrologists, nephrologists, surgeons, obstetricians, pediatricians, general practitioners, medical researchers.
The Journal is indexed in Web of Science, Medline, Scopus, Pub Med, Biological Abstracts, Chemical Abstracts, Excerpta Medica, Index Medicus.
Being an invaluable source of both basic science and clinical research, the Journal "Urology" is best known for its contribution to the education of many generations of Russian scientific and medical professionals. Publication in this journal has become an important measure of scientific and practical significance for the vast majority of doctoral and master's dissertations.
Since 2012 the Journal has been published by Bionika Media Publishing House.
Bionika Media Publishing House seeks to comply with the ethical standards at all stages, ensuring that publication process conforms to the International Committee of Medical Journal Editors Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (http://www.icmje.org/icmje-recommendations.pdf).
Our Primary Objectives
-
Publish high-quality research papers that meet international standards of scientific publications;
-
Further improve the general quality of reviewing and editing of manuscripts submitted for publication;
-
Provide a widest possible dissemination of the published articles among the global scientific community;
-
Extend distribution and indexing of scientific publications in key international citation bases.
Current Issue
No 2 (2026)
- Year: 2026
- Published: 27.05.2026
- Articles: 23
- URL: https://journals.eco-vector.com/1728-2985/issue/view/15230
Original Articles
Resistance of Enterobacterales causing community-acquired urinary tract infections in the Russian Federation in 2024: data from the RESOURCE-2 study
Abstract
Introduction. The problem of rational antimicrobial therapy for urinary tract infections (UTIs) remains highly relevant for physicians of various specialties. Knowledge of the level of antibiotic resistance among UTI pathogens is critically important for the choice of empirical therapy, prevention of recurrence, chronic infection, and complications such as urosepsis and stone formation.
Aim. To analyze antibacterial resistance data for the main pathogens causing community-acquired UTIs, namely Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis, in the Russian Federation in 2024.
Materials and methods. A retrospective analysis was performed on 185,480 urine samples collected in outpatient settings throughout Russia. Microorganism identification was carried out using an automated analyzer and identification systems (VITEK2, MALDI Biotyper). Antimicrobial susceptibility was determined in accordance with the Russian guidelines “Determination of susceptibility to antimicrobial agents” 2024 [14].
Results. Pathogens at a diagnostic titer (≥104 CFU/mL) were isolated in 23.5% (n=43,550) of the analyzed samples. The distribution of pathogens was as follows: E. coli – 64.1%, K. pneumoniae – 13.1%, P. mirabilis – 3.6%. The resistance profile of E. coli varied substantially depending on the demographic group. The most unfavorable situation was observed in adult men, with resistance to fluoroquinolones exceeding 57% and resistance to third-generation cephalosporins approximately 48%, whereas the most favorable situation was observed in pregnant women. Fosfomycin and nitrofurantoin retained the highest activity against E. coli in women, with more than 96% of strains remaining susceptible. K. pneumoniae was characterized by a markedly higher level of resistance to all major classes of antibacterial agents, including critically low susceptibility to meropenem (70.7%). P. mirabilis retained high susceptibility to carbapenems (98.4%) and third-generation cephalosporins (83.9%).
Conclusions. The obtained data highlight the need to take into account the patient’s sex, age, and physiological status when selecting empirical therapy for UTIs. Fosfomycin and nitrofurantoin confirmed their status as first-line agents for uncomplicated UTIs in women. The high resistance of uropathogens to fluoroquinolones and co-trimoxazole necessitates restricting their use. The identified increase in resistance of K. pneumoniae to amikacin requires special attention in the treatment of complicated UTIs.
5-15
Interrelationship between immunological and oxidant disorders in acute gestational pyelonephritis at different trimesters of pregnancy
Abstract
Introduction. Urinary tract infection in pregnant women is one of the most common and formidable causes of miscarriage. The topic of gestational pyelonephritis originates from the high prevalence (up to 10%) and the unresolved nature of a number of pathogenesis problems, namely early and timely diagnostics, accurate assessment of the severity of the inflammatory process, the effectiveness and efficiency of treatment, and the prevention of complications. Despite the great successes of practical medicine in the diagnosis and therapy of acute inflammatory kidney diseases in pregnant women, this area remains relevant to this day. Knowledge of all aspects and mechanisms of the pathological condition is possible only with a clear and deep understanding of all molecular, anatomical and metabolic interactions with the morphofunctional status of the body as an indivisible integral unit. At the same time, one of the most important aspects is to clarify the presence of relationships among the many components of the overall picture of the disease, playing significant roles in pathogenesis.
Objective. establishing the relationship between immune and oxidative disorders in gestational pyelonephritis in different trimesters of pregnancy.
Methodology. The study included 65 women (mean age 30.3±4.2 years), divided into groups: healthy women, pregnant women with pyelonephritis in the first, second and third trimesters of pregnancy. In the plasma of peripheral blood and urine, the immune status indicators and parameters characterizing the oxidant-antioxidant system were studied. After that, the correlation analysis method was used to establish the relationships between the dynamics of the immune and oxidant status indicators in each trimester of pregnancy with gestational pyelonephritis.
Results. Close correlations were revealed between a number of studied immune and oxidative parameters in each trimester of pregnancy in gestational pyelonephritis, which proves and clearly confirms the inherent “tension” among the parameters of immune and oxidative status.
Conclusion. The demonstrated correlation interactions among oxidative and immunological parameters at each level deserve a justified right to be used in interpreting the severity of the pathological process, the effectiveness of the therapy and the need to implement treatment measures.
16-25
Urine cytokine profile in assessing the efficacy of Vesusten and intravesical hyaluronic acid instillations in patients with chronic recurrent cystitis
Abstract
Introduction. Chronic recurrent cystitis (CRC) in women is characterized by frequent exacerbations and the difficulty of achieving stable remission. Local inflammation and impaired urothelial barrier function play a key role in its pathogenesis. The search for objective markers of therapy effectiveness, such as urinary cytokines, is an urgent task.
Objective. To analyze the clinical efficacy and urinary cytokine profile in the treatment of CRC in women with the polypeptide drug Vesusten and intravesical hyaluronic acid instillations.
Materials and Methods. This prospective, open-label, comparative study included 45 patients with CRC, divided into two groups: Group I (n=25) received Vesusten 5 mg IM, 10 injections; Group II (n=20) received intravesical instillations of sodium hyaluronate 40 mg, 4 procedures. Clinical efficacy was assessed using VAS, PPIUS, TUFS scales, and urinary frequency. Urinary cytokine levels (MCP-1, calprotectin, RANTES, MIF, TNF-α, IL-6) were measured by ELISA before and after treatment.
Results. Both groups achieved significant improvement in all clinical parameters (p< 0.05). Group I showed a more pronounced reduction in TUFS score (3.9-fold). Cytokine analysis revealed a significant decrease in MCP-1, calprotectin, and IL-6 in both groups. The key difference was the dynamics of RANTES: Group I showed a trend towards an increase (+8.6%, p=0.412), while Group II showed a significant decrease (p=0.02). The median relapse-free period in Group I was 42.5 weeks, significantly higher than in Group II (38.0 weeks; p< 0.05).
Conclusions. The conducted study demonstrated the effectiveness of Vesusten and intravesical hyaluronic acid instillations in achieving prolonged remission in patients with chronic recurrent cystitis (CRC). Vesusten provides a longer relapse-free period (42.5 vs 38.0 weeks, p< 0.05).
26-32
Carbapenem-resistant urinary tract infection in patients with nephrolithiasis
Abstract
Introduction. Carbapenems belong to reserve antibiotics; however, the frequency of carbapenem-resistant bacterial strains is increasing in hospitals. Resistance of nosocomial Gram-negative strains to carbapenems is a significant problem with a tendency to progress, necessitating close attention to it.
Objective. Analysis of the prevalence of carbapenem-resistant flora in a urology clinic, identifying the most significant factors associated with the resistance of pathogens to medications.
Material and methods. A single-center retrospective study was conducted analyzing 1,720 urine culture results from patients with nephrolithiasis managed at a tertiary care institution in Moscow.
Results. Acquired carbapenem resistance to at least one carbapenem was detected in 5.4% of patients. Carbapenem-resistant Klebsiella pneumoniae (70% of all carbapenem-resistant isolates) and Pseudomonas aeruginosa (13%) were the most frequently identified species. Male sex and age >50 years were identified as significant risk factors. A logistic regression model was constructed to quantify the contribution of major risk factors, demonstrating an area under the receiver operating characteristic curve (ROC-AUC) of 0.88.
Conclusion. The relatively high prevalence of carbapenem-resistant Gram-negative urinary tract infection among patients hospitalized for urological management of nephrolithiasis necessitates further research to identify optimal therapeutic strategies and prevent postoperative infectious complications caused by these pathogens. Moreover, the prevalence rate of carbapenem-resistant bacteria (5.4%) carries important implications for antimicrobial stewardship and pharmaceutical resource allocation in urological inpatient settings.
34-40
Features of urolithiasis recurrence in the Far North regions
Abstract
Aim. To improve the diagnosis and treatment of urolithiasis in the conditions of the Far North.
Materials and methods. The study included 136 patients in whom stone analysis after surgical treatment was done. The patients underwent examination and treatment at Salekhard District Clinical Hospital and Outpatient Department No. 4 of University Clinical Hospital No. 2, Sechenov University. The mean age of the patients was 47.6±11 years. There were 89 men (65.4%) and 47 women (34.6%). Before surgical intervention, stones were located in a calyx in 31 patients (22.8%), in the renal pelvis in 28 (20.6%), in the upper third of the ureter in 17 (12.5%), in the middle third in 9 (6.6%), and in the lower third of the ureter in 51 patients (37.5%). Indications for surgery included frequent episodes of renal colic, hematuria, and chronic calculous pyelonephritis. Preoperatively, 29 patients (21.3%) had recurrent stone formation, whereas in 107 patients (78.7%) the stone was detected for the first time. Extracorporeal shock wave lithotripsy (ESWL) was performed in 24 patients (17.6%), ureteroscopy with lithotripsy in 74 (54.4%), and percutaneous nephrolithotomy in 38 (27.9%). The mineral composition of the stones was characterized by diversity and variability in frequency. In 28 patients (20.6%), the stone consisted of two types of minerals, whereas in 108 (79.4%) it consisted of three types of minerals in different proportions. During the 24-month follow-up period after surgery, no recurrence of stone formation was observed in 45 patients (33.1%), whereas recurrence was diagnosed in 91 patients (66.9%).
Results. Cluster analysis identified four groups of observations that differed in sample size. Cluster 0 was characterized by a high whewellite content (65.612±12.456) with moderate variability of this parameter. The weddellite level in this group was intermediate (31.729±13.551), also with variable values. The key feature of this cluster was the complete absence of postoperative recurrence of urolithiasis: the recurrence rate was 0.000±0.000. Cluster 1 showed the highest whewellite content among all groups (68.798±11.669). At the same time, the weddellite level in this cluster was lower than in cluster 0 and amounted to 24.218±10.583. The most concerning characteristic of this group was the 100% rate of postoperative urolithiasis recurrence (1.000±0.000). Cluster 2 demonstrated the lowest whewellite content among the first three clusters (42.177±16.461), but at the same time had the highest weddellite level (47.983±21.185). In addition, this group showed an increased uric acid content (40.078), exceeding the corresponding values in the other clusters. The risk of urolithiasis recurrence in this group was extremely high: the mean value was 0.971±0.171, corresponding to a recurrence probability of 97.1%. Cluster 3 represented a distinct subgroup, the smallest one, with only 4 observations, and was characterized by a zero standard deviation. Its distinguishing feature was a markedly elevated level of uric acid dihydrate (30.000), which was 2-2.5 times higher than in the other groups. At the same time, the ammonium urate content (20.000) in this subgroup was lower than in the remaining patients.
Conclusion. The course of urolithiasis is determined by the mineral composition of stones. The four-cluster model clearly demonstrated that the probability of recurrence after surgical treatment is associated with the ratio of mineral components within the calculi. Adaptation of these strategies to the harsh conditions of the Far North is of particular importance. Limited sunlight exposure, extreme temperatures, restricted access to fresh foods, and the remoteness of populated areas require careful control of hydration status, correction of vitamin D deficiency, implementation of telemedicine support, and consideration of local dietary traditions when developing dietary recommendations.
41-47
A double-blind, randomized, placebo-controlled, multicenter clinical trial of the efficacy and safety of oral enzyme combination in the complex treatment of patients with exacerbation of chronic recurrent uncomplicated cystitis
Abstract
The treatment of recurrent lower urinary tract infections (RLUTIs) remains unresolved due to increasing antibiotic resistance and the ability of pathogens to form biofilms and parasitize intracellularly, creating microbial communities with biofilm-like properties. Therefore, great importance is placed on studying the effect of combination therapy on recurrent inflammation in the bladder mucosa using alternative enzymatic preparations, such as Wobenzym®. This preparation exhibits anti-inflammatory, immunomodulatory, fibrinolytic, antiplatelet, and anti-edematous effects, as confirmed by several studies.
Based on the above, we have planned and conducted a clinical trial in a group of patients with recurrent lower urinary tract infections.
Study objective: To evaluate the efficacy and safety of Wobenzym® compared to placebo as part of combination therapy in patients with exacerbation of chronic recurrent uncomplicated cystitis.
Materials and methods: The clinical part of the study was conducted in compliance with all GCP requirements, in 20 research centers in the Russian Federation. The study included screening, therapy period and follow-up period – 8 planned visits and unplanned in case of disease relapse. 640 patients were included in the study, 638 patients took the study drug and were randomized into two groups: Wobenzym Group – 320 and Placebo Group – 318 women. As an antibacterial therapy, all patients were prescribed fosfomycin trometamol (Monural®). Group I of patients additionally received Wobenzym®, Group II – Placebo. Comparative analysis did not reveal statistically significant differences between the groups in somatic status and lifestyle, as well as its characteristics (p>0.05). In accordance with the primary endpoint, the incidence of recurrent exacerbation of chronic recurrent uncomplicated cystitis was assessed in the groups. Secondary efficacy criteria included a comparative assessment of the dynamics of changes in the main clinical symptoms; the proportion of patients who reported the absence of pain at the completion visit according to the pelvic pain, urgency, and frequency of urination symptom scale; the proportion of patients with symptoms of a current exacerbation of the disease after 14, 28, 56, and 84 days of therapy according to the patient diary; the dynamics of changes in objective laboratory parameters; the frequency of dysbiosis before and after therapy. The safety of Wobenzym® was also assessed.
Results. In the Wobenzym group, recurrent exacerbation of chronic recurrent uncomplicated cystitis was observed in 12.62% of patients (95% CI: 8.94; 16.29), in the Placebo group - in 24.53% of patients (95% CI: 19.77; 29.28) (p< 0.05). The main symptoms of cystitis resolved statistically faster in patients receiving Wobenzym® (p< 0.05). Laboratory safety parameters were comparable between groups. Wobenzym® therapy was accompanied by lower concentrations of proinflammatory and regulatory cytokines, particularly IL-8 and IL-10, with a clear trend toward increased efficacy in the late stages of observation. In this study, 191 AEs were recorded (86 in the Wobenzym Group and 105 in the Placebo Group).
Discussion. Our results confirm previous studies and the stated pharmacological properties of Wobenzym.
Conclusion. Wobenzym® is a safe and effective combination therapy for lower urinary tract infections, exhibiting anti-inflammatory and immunomodulatory effects to significantly reduce the recurrence of bladder mucosal inflammation.
48-59
Microbiological efficacy of the dietary supplement Ciurol N against uropathogens: a pilot study
Abstract
Background. Dietary supplements play an important role in the treatment and prevention of urinary tract infections (UTIs). However, their mechanism of action often remains unclear.
Aim. To study the anti-adhesive, antibiofilm, and direct antibacterial activity of the dietary supplement Ciurol N against uropathogenic bacteria causing UTIs.
Materials and methods. The study material consisted of uropathogenic microorganisms (127 strains) isolated from urine samples of 120 women with recurrent UTIs. Five cultures each of the most commonly detected uropathogens were selected: Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, and Enterococcus faecalis (20 samples in total). The anti-adhesive activity of Ciurol N was assessed by changes in the adhesion index (AI), antibiofilm activity by changes in the optical density of biofilms, and the direct antibacterial effect by the number of viable bacteria after interaction with the tested product, with calculation of the minimum inhibitory concentration (MIC). Control samples consisted of bacterial suspensions in meat-peptone broth at a concentration of 1×102 CFU/mL, whereas experimental samples consisted of the same bacterial concentration supplemented with Ciurol N.
Results. In the experimental samples, 24 hours after the start of the study, AI values compared with the control were lower by 2.4-fold for E. coli, 2.4-fold for K. pneumoniae, 2.2-fold for P. mirabilis, and 2.8-fold for E. faecalis. At the same time point after the addition of Ciurol N, the optical density values of biofilms were 2.2-2.8 times lower than in the control for all studied uropathogens. A direct antibacterial effect of Ciurol N was also demonstrated, as evidenced by suppression of colony growth of the studied microorganisms. Overall, for all uropathogens, a stable antibacterial effect persisted for 9 hours of observation. After 12 hours, an increase in the number of viable colonies was observed; however, their number remained substantially lower than in the control.
Conclusions. The results of this study indicate that the dietary supplement Ciurol N has anti-adhesive, antibiofilm, and direct antibacterial activity in vitro against the main uropathogens. These findings may be useful for planning studies of the clinical efficacy of Ciurol N in patients with UTIs.
60-68
Adaptation and validation of the Russian-language version of the Peyronie’s disease questionnaire, PDQ-RU
Abstract
Introduction. Peyronie’s disease (PD) is characterized by fibrosis of the tunica albuginea of the penis with plaque formation within its thickness. It manifests as penile pain, penile curvature, and erectile dysfunction, with a psychological impact on affected men.
Aim. To translate the questionnaire into Russian and to adapt and validate the Russian-language version of the PDQ (Peyronie’s Disease Questionnaire) for use in clinical practice and research.
Materials and methods. The PDQ was translated in this study. The translation process was carried out in accordance with recommendations for validation and adaptation. The study included 36 patients with Peyronie’s disease who presented to the Urology Clinic of Sechenov University from February 2025 to May 2025. They completed the PDQ at the initial visit and again 7 days later at a follow-up visit.
Results. Internal consistency and reliability were assessed using Cronbach’s alpha coefficient, which demonstrated excellent consistency at both visits. For all questions, the results of the two visits showed high correlation, greater than 0.8, indicating stable reproducibility of the results.
Clinical significance. Owing to the translation and validation of the PDQ into Russian, PDQ-RU (Peyronie’s Disease Questionnaire-Russia), clinicians now have a valuable and convenient tool for assessing clinical manifestations and quality of life in patients with Peyronie’s disease.
Limitations: factor analysis to assess structural validity was not feasible due to the small sample size (KMO < 0.7); absence of an external validation criterion; and the single-center design of the study.
Conclusion: Translation and validation of the PDQ for Russian-speaking patients provides a useful, convenient, and reliable tool for clinical assessment of quality of life as well as treatment outcomes in patients with PD.
69-75
Correlation between functional and ultrastructural status of spermatozoa (based on transmission electron microscopy and sperm-hyaluronan binding assay)
Abstract
Introduction. Standard diagnostic testing for male infertility includes a spermogram in accordance with current World Health Organization (WHO) recommendations. However, a basic ejaculate examination is insufficient to identify the causes of unsuccessful conceiving attempts, early pregnancy terminations, and ineffective ART protocols. Modern methods include transmission electron microscopy (TEM) of sperm, which allows visualization of their ultrastructural elements, and the HBA (Hyaluronan Binding Assay) test, which assesses the functional maturity of sperm. The clinical significance of these methods lies in their ability to detect hidden disorders of spermatogenesis, assess sperm DNA quality, and determine the functional readiness of gametes for fertilization.
Objective. To establish a relationship between the level of functional maturity of spermatozoa, determined using the HBA test, and the presence of ultrastructural changes detected using electron microscopic examination of spermatozoa.
Materials and methods. The retrospective study included 98 men who sought medical help due to marital infertility. The average age was 33.5±4.2 years; the duration of infertility was 2.4±1.9 years. All men underwent ultrasound examination of the scrotum, determination of testosterone, LH, FSH, prolactin, and estradiol levels in the blood serum, spermogram, HBA test, and EMIS. Sperm analysis for both tests was performed from one portion of ejaculate. The men were stratified into two groups: group 1 – patients with HBA test < 65% (n=21) and group 2 – with HBA test > 65% (n=77). The study groups did not differ in age, anthropometric data, hormonal profile indicators, incidence of varicocele, and bad habits.
Results. Semen analysis revealed a significant reduction (p< 0.01) in the main ejaculate parameters in the group with impaired functional sperm maturity compared with the control group: sperm concentration (38.8±10.3 million/ml vs. 64±5.8 million/ml, respectively), total sperm count per ejaculate (125±32,5 million vs 229±23,1 million), progressive motility (44,8±5,4% vs 60±2,5%), and normal morphology (1,9±0,7% vs 3,6±0,42%). According to TEM data, the presence of an acrosome on the sperm head (R=0,343, p=0,002) and an intact postacrosomal sheath (R=0,248, p=0,024) showed a weak positive correlation with the HBA test, whereas reduced acrosomal size (R=−0,227, p=0,039) and reacted acrosomes (R=−0,295, p=0,007) demonstrated a weak negative correlation with the HBA test. Chromatin decondensation (R=−0,353, p=0,001) and the presence of a cytoplasmic droplet on the sperm head or neck (R=−0,427, p=0,001) were negatively correlated with the HBA test. In patients with an HBA test value < 65%, there was a positive correlation with the presence of an acrosome (R=0,759, p=0,0001), its normal position (R=0,557, p=0,009), and normal axonemal structure (R=0,449, p=0,041), and a negative correlation with reduced acrosomal size (R=−0,541, p=0,011), reacted acrosomes (R=−0,683, p=0,001), and abnormal chromatin structure (R=−0,467, p=0,033) on TEM.
Conclusion. Reduced sperm binding capacity to hyaluronic acid is associated with ultrastructural sperm abnormalities. Assessment of functional sperm maturity using the HBA test serves as a predictor of ultrastructural defects in spermatozoa and is of considerable clinical relevance.
76-84
Evaluation of the efficiency of two-stage therapy with Vitaprost® (suppositories → tablets) in patients with chronic prostatitis and lower urinary tract symptoms after failure of previous therapy: results of a prospective non-interventional real-world study (LEVITATE)
Abstract
Aim. To evaluate the clinical efficiency and safety of a two-stage treatment regimen with Vitaprost® (rectal suppositories followed by change to the tablet form) in patients with chronic prostatitis (CP) and lower urinary tract symptoms (LUTS) after failure of previous therapy in real-world clinical practice.
Materials and methods. A prospective non-interventional study, LEVITATE (Long-term Evidence for VITAprost in Treatment of prostatE diseases), was carried out. The analysis included 30 men with CP and LUTS (mean age 36.1±4.6 years) after ineffective previous therapy. Patients received Vitaprost® suppositories for 30 days followed by 30 days of tablet therapy. Patients were also followed for 90 days. Assessments were performed at four visits using the NIH-CPSI, IPSS, and SF-36 questionnaires, transrectal ultrasound, and uroflowmetry. Statistical analysis was performed using the Friedman test.
Results. The total NIH-CPSI score decreased from 12.8±1.3 to 8.6±0.9 (Δ−4.2; p< 0.0001). Improvement in prostate structure on transrectal ultrasound was observed in most patients; the proportion of fibrotic changes decreased from 46.7% to 16.7%. Prostate size decreased from 26.1±8.4 to 24.1±6.8 mm (Δ-2,0; p< 0.0001). Improvement in voiding parameters and quality of life was also noted. No adverse events were recorded.
Conclusion. Two-stage therapy with Vitaprost® is effective in patients with CP and LUTS after failure of previous treatment, providing a significant reduction in symptoms, improvement in the morphological and functional state of the prostate and voiding parameters, with high adherence and a favorable safety profile.
85-90
Effect of prostate-derived complex peptide preparations on erectile function in patients with chronic prostatitis
Abstract
Disturbances of microcirculation and congestive processes in prostatic tissue play a key role in the development of chronic prostatitis. High-frequency Doppler ultrasonography of the penile vessels is used for objective assessment of erectile function (EF) in patients with chronic prostatitis (CP). A pathogenetically oriented treatment option for chronic abacterial prostatitis is the use of peptide bioregulators, including Prostatilen, which has been used for more than 30 years.
Aim. To evaluate the effect of a complex prostate-derived peptide preparation on erectile function and penile arteriolar blood flow in patients with chronic abacterial prostatitis.
Materials and methods. A total of 50 patients aged 25 to 64 years with CP and concomitant erectile dysfunction (ED), who received Prostatilen-AC rectal suppositories (30+180 mg) once daily at bedtime for 10 days, are included in the study. Before and after treatment, the following parameters were assessed: EF using the IIEF-5 questionnaire, as well as peak systolic velocity (Vas) and mean linear velocity (Vam) of arterial blood flow in the vessels of the non-erect penis using high-frequency Doppler ultrasonography.
Results. Before treatment, mild ED was identified in 8/50 (16%) patients, moderate ED in 24 (48%), and severe ED in 18 (36%) patients. The mean IIEF-5 score was 12.8±5.1. According to Doppler assessment, marked microcirculatory disturbances were detected in 26/50 (52%) patients. After treatment with Prostatilen-AC, the mean IIEF-5 score increased significantly compared with baseline, from 12.8±5.1 to 17.8±4.3 (p< 0.05), respectively. After therapy, all patients demonstrated a reduction in the severity of clinical manifestations of ED: in 6 (12%) patients symptoms were absent, 20 (40%) patients had mild ED, 14 (28%) had moderate ED, and only 7 (14%) patients retained severe ED. Therapy was also associated with a statistically significant improvement in penile arteriolar blood flow parameters in the observed patients: mean Vas increased from 2.78±0.26 cm/s before treatment to 3.41±0.31 cm/s after treatment (p< 0.05); mean Vam increased from 0.56±0.11 cm/s to 0.88±0.12 cm/s, respectively (p< 0.05).
Conclusion. Treatment of patients with CP and concomitant ED with a complex prostate-derived peptide preparation contributed to a reduction in the severity of clinical manifestations of ED. An objective criterion of treatment efficacy, reflecting improvement of microcirculation in the penile vessels, is provided by the results of high-frequency Doppler ultrasonography of the penile vessels. Improvement in penile arteriolar blood flow following treatment in patients with manifestations of ED was indicated by increases in its main Doppler parameters, Vas and Vam.
92-98
The effectiveness of Prostatex Plus in the treatment of patients with chronic abacterial prostatitis categories III B
Abstract
Introduction. Chronic prostatitis is a pressing medical and social problem. Despite numerous experimental and clinical studies evaluating the effectiveness of various therapeutic agents, optimal treatment regimens for patients with chronic prostatitis have yet to be developed.
Objective: to study the efficacy and safety of Prostatex Plus in the treatment of chronic abacterial prostatitis category III B in comparison with Prostatilen.
Materials and methods. An open-label, randomized cohort study was conducted involving 60 patients aged 37 to 57 years with chronic abacterial prostatitis, category III B. The main group (n=30) received Prostatex Plus 10 mg rectally once daily at night as part of combination therapy, while the comparison group (n=30) received Prostatilen 3 mg rectally once daily at night as part of combination therapy. Therapy with both drugs was administered for 20 days. Based on the NIH-CPSI, IPSS, and IIEF-5 questionnaires, clinical data, and the results of laboratory and instrumental studies, the efficacy and safety of the drugs were assessed in a comparative aspect for 14 days after treatment.
Results. Patients with chronic abacterial prostatitis of categories III B treated with prostate extract-containing medications experienced a reduction in prostate parameters and swelling, leading to normalization of urinalysis and prostate secretion parameters, stable uroflowmetry and ultrasound data, and a reduction in symptoms and complaints. This, in turn, translates into improved urination quality, a reduction in pain and cardiac erectile dysfunction, and an increased quality of life. Furthermore, a comparative analysis demonstrated the greater efficacy of Prostatex Plus compared to Prostatilen.
Discussion. Currently, there is practically no information about the use of Prostatex Plus in patients with chronic prostatitis. Normalization of indicators of general urinalysis and prostate secretion, improvement of uroflowmetry and ultrasound data, relief of clinical symptoms indicate the high effectiveness of the drug in the treatment of chronic prostatitis.
Conclusions. Prostatex Plus is highly effective in the treatment of chronic abacterial prostatitis of categories III B. The use of Prostatex Plus significantly improves clinical and instrumental parameters.
99-105
Laparoscopic ileal ureteral reconstruction
Abstract
Restoration of urinary tract continuity using isolated segments of the small intestine is required in cases of extensive ureteral defects of various origins. In recent years, several publications have reported the use of laparoscopic techniques for performing ileoureteroplasty. The aim of the research is to present the outcomes of laparoscopic intestinal ureteral reconstruction.
Materials and methods. From 2001 to 2026, small bowel ureteral reconstruction was performed in 249 patients. Laparoscopic ileoureteroplasty has been carried out by our team since 2013, and during this period we have accumulated experience with 101 such operations (50.2%), involving a total of 109 ureters. Among these patients, there were 44 men (43.6%) and 57 women (56.4%), with a mean age of 48.8±1.6 years. Unilateral ileoureteroplasty was performed in 93 patients (92.1%), and bilateral procedures in 8 patients (7.9%).
Results. Early postoperative complications occurred in 6 patients (5.9%). There were no fatal outcomes. Late complications were followed up in 89 patients over a period ranging from 3 to 254 months (mean 66±2 months) after surgery and developed in 5 patients (5.6%). Urinary tract urodynamics on the operated side improved in all patients. According to nephroscintigraphy, kidney function after ileoureteroplasty improved in 98 patients (97.0%), remained at the same level in 1 (1.0%) and worsened in 2 (2.0%) patients.
Discussion. An isolated segment of the ileum is the best and most versatile substitute for the reconstruction of extensive ureteral defects. In most patients, ileoureteroplasty can be successfully performed using a laparoscopic approach.
Conclusion. Laparoscopic ileoureteroplasty reduces surgical trauma and shortens the duration of hospital stay.
106-113
Clinical and morphological rationale for urinary continence recovery after robot-assisted nervesparing radical prostatectomy
Abstract
Objective. To compare the functional, clinical and morphological results of a standard robot-assisted nerve-sparing radical prostatectomy and with the use of the Retzius-sparing technique. To justify the differences in the rate and quality of urinary continence recovery based on the results of morphological examination.
Materials and methods. A prospective and retrospective analysis was conducted on two groups of patients (n=223) who underwent nerve-sparing robot-assisted radical prostatectomy between 2013 and 2023. The first group included 110 patients who underwent nerve-sparing robot-assisted radical prostatectomy with partial preservation of the Retzius space, while the second group consisted of 113 patients who underwent standard nerve-sparing robot-assisted radical prostatectomy. The mean age in groups 1 and 2 was 59,95±6,63 and 59,88±6,23 years, respectively (p=0,928). Body mass index was 27,46±3.38 and 27,02±3,41 (p=0,399); PSA level was 8,13 (5,2–10) and 7,67 (5,1–9) ng/ml (p=0,508); the IIEF-5 score was 22,91±3,43 and 23,12±4,26 in groups 1 and 2, respectively (p=0,466). No statistically significant differences were observed between the groups before surgery.
Results: One week after urethral catheter removal, in the group of patients who underwent nerve-sparing robot-assisted radical prostatectomy with partial preservation of the Retzius space, 52,18% of patients were fully continent; in the second group, 34,53% of patients were continent (p=0,019). One month after catheter removal, urine was fully retained by 67,14% and 58,18% of patients in groups 1 and 2, respectively (p=0,002). At three months, 93,82% and 89,17% of patients were continent (p=0,105), and at six months, 98,21% and 96,84% of operated patients were continent (p=0,426). After 12 months of follow-up, urine was fully retained by 98,53% and 97,17% of patients (p=0,326). Morphological examination following standard nerve-sparing radical prostatectomy reveals a minimal number of nerve fibers per unit area in the prostatic fascia. In contrast, when using the partial preservation of the Retzius space technique, nerve fibers are not detected in the prostatic fascia.
Conclusions: Nerve-sparing robot-assisted radical prostatectomy using a modified technique for preservation of the Retzius space demonstrates advantages in the rate of urinary continence recovery within the first three months after urethral catheter removal compared to the standard procedure. According to morphological data, this technique allows for the preservation of vascular-neural and ligamentous-fascial structures involved in maintaining continence.
114-121
Continence recovery after robotic-assisted radical retzius-sparing prostatectomy
Abstract
Objective. To assess time to urinary continence recovery after Retzius-sparing robot-assisted radical prostatectomy (RS-RARP) and to describe early perioperative and oncological outcomes.
Materials and methods. A retrospective analysis was performed of patients who underwent RS-RARP in 2022–2024. The primary endpoint was time to complete urinary continence (0 pads/day). Time-to-event analysis (continence recovery) was carried out using the Kaplan–Meier method, with cumulative event probability visualized as (1−S(t)) and 95% confidence intervals calculated.
Results. A total of 344 patients were included. On day 1 after urethral catheter removal, complete continence was observed in 90,1% of patients (0–1 pad/day in 97,3%). Complete continence rates were 92,1% at 1 month and 97,2% at 12 months. Mean time to continence recovery was 0,7 months (95% CI 0,428–0,973). Positive surgical margins were detected in 9% of cases; no biochemical recurrence was recorded during follow-up. Mean operative time was 113 min and mean blood loss was 121 mL.
Conclusions. RS-RARP provides rapid recovery of urinary continence with high early complete continence rates and acceptable perioperative and short-term oncological outcomes. Comparative studies versus standard RARP and comprehensive analyses of oncological and functional outcomes are needed to further clarify the advantages and limitations of this technique.
122-127
Injury to the rectum during laparoscopic radical prostatectomy: is it a serious complication?
Abstract
Introduction. Rectal injury is a serious intraoperative complication of radical prostatectomy (RP), with its reported incidence varying widely in the literature from 0 to 20.39%. Delayed diagnosis of rectal injury increases the risk of peritonitis, sepsis, and rectourethral fistula formation. The optimal strategy for prevention and management of this complication remains a matter of debate.
Aim. To analyze the causes of rectal injury during laparoscopic radical prostatectomy (LRP) and the efficiency of therapeutic measures based on the authors’ own experience in comparison with the published literature.
Materials and methods. A retrospective analysis was performed of 519 LRP procedures carried out at a single center between 2014 and 2023. Intraoperative rectal injury was identified in 3 patients (0.58%). In all cases, LRP was performed via an extraperitoneal approach. A bubble test was used for intraoperative diagnosis of rectal injury. All defects were closed with a two-layer suture using absorbable material. Postoperative management included antibiotic therapy, parenteral nutrition for 6-9 days, and prolonged bladder catheterization for 9-14 days.
Results. The length of the rectal defect ranged from 1.0 to 3.5 cm. There was no need for conversion to open surgery or colostomy. No surgical complications, suture failure, or signs of oncological disease progression were recorded during a follow-up period of 46-113 months.
Discussion. Intraoperative rectal injury during LRP is a rare complication. Timely intraoperative diagnosis, including the use of a bubble test, and immediate two-layer closure of the defect make it possible to minimize the risk of severe postoperative complications and rectourethral fistula formation.
Conclusion. Previous radiation therapy and prior surgery increase the risk of rectal injury, whereas intraoperative closure of the defect usually does not require colostomy and rarely results in complications. The role of preoperative bowel preparation and parenteral nutrition in preventing suture failure remains unclear.
128-134
Clinical case
Endoscopic extraction of a foreign body from the right kidney
Abstract
Foreign bodies in the upper urinary tract are relatively rare. Publications on this topic primarily consist of clinical case reports describing the removal of foreign bodies discovered after surgical interventions. However, in modern combat trauma care, the relevance of this issue has increased. In cases of penetrating abdominal or lumbar injuries involving the kidney, the penetrating projectile may remain in the renal parenchyma and subsequently migrate or initially lodge in the pelvicalyceal system. In the vast majority of cases, patients present with multiple (18.6%) or combined (71.2%) injuries, making minimally invasive surgical approaches the preferred method for foreign body removal. Modern technologies allow for the use of percutaneous and/or transurethral techniques in such situations. In this context, we present a clinical case of endoscopic removal of a fragment from the pelvicalyceal system of the right kidney.
135-139
Simultaneous surgeries on the lower urinary tract
Abstract
The article presents a clinical case of successful simultaneous laparoscopic intervention in a 70-year-old patient with combined diseases of the lower urinary tract: large benign prostatic hyperplasia (113 cm3) and iatrogenic stricture of the lower third of the right ureter, which developed after contact ureterolithotripsy. The patient’s complications included an obstructive ureteral stone, stricture formation with hydronephrosis, secondary pyelonephritis, prostate abscess after a transrectal biopsy, and acute urinary retention, which required a comprehensive surgical approach.
The intervention involved laparoscopic transvesical adenomectomy and Boari ureteralplasty. The surgery lasted 120 minutes, and the blood loss was 100 ml. The postoperative period was uneventful. Follow-up examinations after 3 and 6 months showed a significant improvement in functionality. The article presents a clinical case of successful simultaneous laparoscopic intervention in a 70-year-old patient with combined diseases of the lower urinary tract: large benign prostatic hyperplasia (113 cm3) and iatrogenic stricture of the lower third of the right ureter, which developed after contact ureterolithotripsy. The patient’s complications included an obstructive ureteral stone, stricture formation with hydronephrosis, secondary pyelonephritis, prostate abscess after a transrectal biopsy, and acute urinary retention, which required a comprehensive surgical approach.
The intervention involved laparoscopic transvesical adenomectomy and Boari ureteralplasty. The surgery lasted 120 minutes, and the blood loss was 100 ml. The postoperative period was uneventful. Follow-up examinations at 3 and 6 months demonstrated a significant improvement in functional parameters: the maximum urine flow rate (Qmax) increased from 5.3 to 20.2–23.4 ml/s, and the residual urine volume decreased from 130 to 0 ml. There was an improvement in kidney function (decreased serum creatinine levels and increased GFR) and resolution of hydronephrosis. No signs of detrusor overactivity, vesicoureteral reflux, or reflux pyelonephritis were detected, indicating that the anastomosis was successful and that the bladder function was preserved.
The authors emphasize the main advantages of the simultaneous approach: the radical treatment of multiple diseases with a single anesthesia and hospitalization, the reduction of the overall rehabilitation period, and the decrease in the overall surgical risk. This observation illustrates the relevance of simultaneous surgeries in modern urology, especially for elderly polymorbid patients, and demonstrates their high efficiency and safety with careful preoperative planning. The introduction of such techniques into routine practice can optimize the treatment of patients with complex combined diseases of the lower urinary tract.
140-145
Tuberculosis of the male genital organs as the first manifestation of generalized tuberculosis
Abstract
Abstract. Urogenital tuberculosis is difficult to diagnose in the general healthcare network because it has no pathognomonic symptoms, and there is no screening for urogenital tuberculosis, which complicates its timely diagnosis.
This article presents a clinical case of generalized tuberculosis that first manifested as a lesion of the external genital organs. A high level of clinical suspicion for tuberculosis prompted special investigations using widely available methods. Real-time PCR diagnostics allowed to identify tuberculosis of the male genital organs as the first manifestation of generalized tuberculosis. We present a rare case of urogenital tuberculosis diagnosed by ejaculate analysis, as well as a successful treatment outcome.
The key factor in timely diagnosis of tuberculosis is physician awareness, which is based on a certain minimum level of knowledge about the infection.
146-150
Prostatic leiomyoma
Abstract
Introduction. Prostatic leiomyoma is a rare benign mesenchymal tumor arising from the smooth muscle fibers of the prostatic stroma. Clinically, it may mimic benign prostatic hyperplasia or a malignant lesion, which makes preoperative diagnosis difficult.
We present a clinical case of a 52-year-old patient with severe lower urinary tract symptoms and a normal prostate-specific antigen level (0.65 ng/mL) who was diagnosed with prostatic leiomyoma complicated by significant bladder outlet obstruction. We also analyze the diagnostic and surgical aspects of the management of this disease.
According to the diagnostic work-up, including ultrasonography, magnetic resonance imaging, and uroflowmetry, a prostatic mass classified as PI-RADS 2 was identified. After prostate biopsy, laser enucleation was performed. Due to the high tissue density, conversion to transvesical removal of the enucleated prostatic lobes was required. Histological examination confirmed the diagnosis of prostatic leiomyoma.
Conclusion. Prostatic leiomyoma is one of the rarest benign mesenchymal tumors encountered in urological practice. Typical manifestations include symptoms of bladder outlet obstruction in the presence of a normal PSA level; nevertheless, differential diagnosis with prostate cancer remains mandatory. Since no standard treatment strategy for prostatic leiomyoma has been established, management should be individualized, taking into account tumor size, symptom severity, and the patient’s overall somatic status.
151-155
Buschke–Loewenstein tumor of the penis
Abstract
Giant condyloma of Buschke–Loewenstein is a rare benign tumor characterized by viral etiology, slow growth, the ability to cause disfigurement of the affected areas and a certain potential for malignancy. The main treatment option for this disease is surgery. Our clinical case is dedicated to the successful surgical treatment of a 57-year-old patient, in whom giant condyloma of Buschke–Loewenstein of the penis developed over 10 years without malignant transformation.
156-159
Resolution
Resolution of the expert forum “Interdisciplinary aspects of the management of patients with urinary tract infection and chronic pelvic pain. The role of nitrofurans in the treatment of urinary tract infection”
Abstract
On February 14, 2026, the expert forum «Interdisciplinary Aspects of the Management of Patients with Urinary Tract Infection and Chronic Pelvic Pain» was held within the framework of the activities of Committee on Infection of the Russian Society of Urologists. The meeting addressed current issues in the diagnosis and comprehensive treatment of patients with urinary tract infection and chronic pelvic pain. The specialists focused on the pathogenetic mechanisms underlying pain syndrome in this category of patients, the relationship between functional disorders of the lower urinary tract and urinary tract infection, as well as current data reflecting changes in the understanding of the etiological structure of these conditions. Following the meeting, the experts concluded that mandatory interdisciplinary collaboration among urologists, obstetricians, gynecologists, neurologists, and other specialists is necessary, as is expansion of the diagnostic work-up through the mandatory inclusion of cytological and morphological methods in the diagnostic work-up for patients with recurrent infectious diseases of the urinary tract. In specifying the issues of antibacterial therapy for urinary tract infection in the context of the global problem of antibiotic resistance, the feasibility of using soluble nitrofuran formulations was substantiated in order to provide reliable etiological control and prevention of infectious complications. The experts also emphasized the importance of pathogenetic therapy aimed at stimulating neuroregeneration processes and correcting psychological and emotional disorders for effective pain relief and achievement of stable remission.
161-171
Obituary
In memory of professor Valentin Ilyich Isaenko (11.07.1937– 29.01.2026)
172-172

